Please login to view this media
- Talk
- 22/09/2021
- UK
Clinical and Cost-effectiveness of a New Care Pathway for Patients with Pain at Three Months After Total Knee Replacement: The STAR Randomised Controlled Trial
Description
In this presentation, Andy Jones delivers a comprehensive overview of the results from the Star trial, a clinical study aimed at evaluating a new care pathway for patients experiencing chronic pain prior to knee replacement surgery. He begins by introducing himself and acknowledging the contributions of participating hospitals and academic units to the study.
The trial addresses the significant issue of post-operative chronic pain, noting the complexity surrounding its management, with approximately 1 in 5 patients facing pain even after knee surgery. The Star trial was designed to create a multidisciplinary approach to identify and manage these patients effectively.
Following a detailed description of the screening process and the patient management pathway, which includes assessments using standardized scales and follow-up appointments, Jones presents the trial's findings. The study involved over 5,000 patients, 363 of whom were randomized between the new pathway and usual care. Primary outcomes showed significant reductions in pain severity and interference for those in the care pathway, though improvements in the Oxford knee score, while statistically significant, did not meet clinical thresholds.
Cost-effectiveness analysis indicated notable savings, and patient feedback suggested high levels of acceptance for the new care approach. Jones highlights the trial's strengths, such as its multicenter design and generalizability, while also acknowledging limitations like low response rates in the screening process. He concludes by mentioning future directions for longer-term data and ongoing research into chronic pain management, inviting questions from the audience.